Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsINJECTIONGeneric

PLASMA-LYTE R IN PLASTIC CONTAINER

CALCIUM CHLORIDE; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM ACETATE; SODIUM CHLORIDE; SODIUM LACTATE

Standard Dose
36.8MG/100ML;30.5MG/100ML;74.6MG/100ML;640MG/100ML;496MG/100ML;89.6MG/100ML
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary

Approval overview PLASMA-LYTE R IN PLASTIC CONTAINER is listed in Drugs@FDA under application 017438 (NDA).

Review priority: STANDARD Marketing status: Discontinued Active ingredient CALCIUM CHLORIDE; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM ACETATE; SODIUM CHLORIDE; SODIUM LACTATE Form and strength INJECTABLE;INJECTION - 36.8MG/100ML;30.5MG/100ML;74.6MG/100ML;640MG/100ML;496MG/100ML;89.6MG/100ML Sponsor BAXTER HLTHCARE Submission history Latest submission status date: 2002-04-03 00:00:00.

Structured Monograph

Clinical summary

Approval overview PLASMA-LYTE R IN PLASTIC CONTAINER is listed in Drugs@FDA under application 017438 (NDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient CALCIUM CHLORIDE; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM ACETATE; SODIUM CHLORIDE; SODIUM LACTATE Form and strength INJECTABLE;INJECTION - 36.8MG/100ML;30.5MG/100ML;74.6MG/100ML;640MG/100ML;496MG/100ML;89.6MG/100ML Sponsor BAXTER HLTHCARE Submission history Latest submission status date: 2002-04-03 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Discontinued
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.